1 LATANOPROST | 2760 of 1,0280 | 4020 prescriptions Less than 1% of all prescriptions | 4020 | 1280 patients 20% of all patients | 1280 patients 20% of all patients | |
2 LUMIGAN (BIMATOPROST) | 970 of 7480 | 2060 prescriptions Less than 1% of all prescriptions | 2060 | 550 patients 9% of all patients | 550 patients 9% of all patients | |
3 TRAVATAN Z (TRAVOPROST) | 940 of 7670 | 1690 prescriptions Less than 1% of all prescriptions | 1690 | 480 patients 8% of all patients | 480 patients 8% of all patients | |
4 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 1270 of 7830 | 1100 prescriptions Less than 1% of all prescriptions | 1100 | 430 patients 7% of all patients | 430 patients 7% of all patients | |
5 TIMOLOL MALEATE | 2400 of 9180 | 760 prescriptions Less than 1% of all prescriptions | 760 | 330 patients 5% of all patients | 330 patients 5% of all patients | |
6 DORZOLAMIDE HCL | 1020 of 5870 | 660 prescriptions Less than 1% of all prescriptions | 660 | 240 patients 4% of all patients | 240 patients 4% of all patients | |
7 RESTASIS (CYCLOSPORINE) | 1040 of 7020 | 710 prescriptions Less than 1% of all prescriptions | | 310 patients 5% of all patients | < 11 | |
8 COMBIGAN (BRIMONIDINE TARTRATE/TIMOLOL) | 1640 of 8250 | 740 prescriptions Less than 1% of all prescriptions | | 240 patients 4% of all patients | < 11 | |
9 BESIVANCE (BESIFLOXACIN HCL) | 360 of 2160 | 1910 prescriptions Less than 1% of all prescriptions | | 1590 patients 25% of all patients | < 11 | |
10 LOTEMAX (LOTEPREDNOL ETABONATE) | 210 of 3850 | 1920 prescriptions Less than 1% of all prescriptions | | 1320 patients 21% of all patients | < 11 | |
11 SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TART) | 680 of 4080 | 500 prescriptions Less than 1% of all prescriptions | | 190 patients 3% of all patients | < 11 | |
12 PREDNISOLONE ACETATE | 2470 of 9940 | 1090 prescriptions Less than 1% of all prescriptions | | 980 patients 15% of all patients | < 11 | |
13 BRIMONIDINE TARTRATE | 1910 of 7580 | 410 prescriptions Less than 1% of all prescriptions | 410 | 160 patients 3% of all patients | 160 patients 3% of all patients | |
14 AZOPT (BRINZOLAMIDE) | 1090 of 5150 | 370 prescriptions Less than 1% of all prescriptions | 370 | 170 patients 3% of all patients | 170 patients 3% of all patients | |
15 RESTASIS MULTIDOSE (CYCLOSPORINE) | 550 of 2610 | 380 prescriptions Less than 1% of all prescriptions | 380 | < 11 | < 11 | |
16 ALPHAGAN P (BRIMONIDINE TARTRATE) | 1280 of 6040 | 230 prescriptions Less than 1% of all prescriptions | 230 | 130 patients 2% of all patients | 130 patients 2% of all patients | |
17 COSOPT PF (DORZOLAMIDE/TIMOLOL/PF) | 310 of 1450 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
18 BROMSITE (BROMFENAC SODIUM) | 90 of 440 | 620 prescriptions Less than 1% of all prescriptions | 620 | 450 patients 7% of all patients | 450 patients 7% of all patients | |
19 NEOMYCIN-POLYMYXIN-DEXAMETH (NEOMYCIN/POLYMYXIN B/DEXAMETHA) | 870 of 5010 | 790 prescriptions Less than 1% of all prescriptions | | 610 patients 10% of all patients | < 11 | |
20 PAZEO (OLOPATADINE HCL) | 780 of 3400 | 240 prescriptions Less than 1% of all prescriptions | 240 | 110 patients 2% of all patients | 110 patients 2% of all patients | |
21 ALREX (LOTEPREDNOL ETABONATE) | 40 of 360 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
22 VALACYCLOVIR (VALACYCLOVIR HCL) | 450 of 1690 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
23 ACYCLOVIR | 550 of 1830 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 XIIDRA (LIFITEGRAST) | 590 of 2310 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
25 ZIOPTAN (TAFLUPROST/PF) | 370 of 1160 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
26 PROLENSA (BROMFENAC SODIUM) | 1240 of 3200 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 ERYTHROMYCIN (ERYTHROMYCIN BASE) | 1170 of 3770 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |